Guenter R. Janhofer
Keine laufenden Positionen mehr
Profil
Guenter R.
Janhofer worked as a Medical Director at Desitin Arzneimittel GmbH and as Vice President-Global Medical & Scientific Affairs at Merck & Co., Inc. He also served as Chief Medical Officer & Head-Development at BTG Ltd.
from 2012 to 2015 and as Head of Development at BTG International, Inc. Dr. Janhofer holds a doctorate degree from Ruhr-Universität Bochum, the University of Hamburg, and the Technical University of Berlin.
Ehemalige bekannte Positionen von Guenter R. Janhofer
| Unternehmen | Position | Ende |
|---|---|---|
Desitin Arzneimittel GmbH
 Desitin Arzneimittel GmbH Pharmaceuticals: MajorHealth Technology Desitin Arzneimittel GmbH manufactures pharmaceutical products for neurological and psychiatric illnesses. Its products are geared towards the treatment of epilepsy, migraine and Parkinson's disease. The company was founded in 1919 and is headquartered in Hamburg, Germany. | Technik-/Wissenschafts-/F&E-Leiter | - |
| MERCK & CO., INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
BTG International, Inc.
 BTG International, Inc. Investment ManagersFinance BTG International Inc. (BTG International) is a venture capital subsidiary of BTG Ltd founded in 1981. The firm is headquartered in West Conshohocken, Pennsylvania. | Corporate Officer/Principal | - |
| BTG | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Guenter R. Janhofer
| University of Hamburg | Doctorate Degree |
| Ruhr-Universität Bochum | Doctorate Degree |
| Technical University of Berlin | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
BTG Ltd.
 BTG Ltd. Pharmaceuticals: MajorHealth Technology BTG Ltd. is a global healthcare company, which focuses on interventional medicine that can help physicians to treat patients through minimally invasive procedures. It operates through the following segments: Product, Licensing, and Other. The firm's products include CroFab, DigiFab, Voraxage. The company was founded on December 12, 1991 and is headquartered in Farnham, the United Kingdom. | Health Technology |
BTG International, Inc.
BTG International, Inc. Investment ManagersFinance BTG International Inc. (BTG International) is a venture capital subsidiary of BTG Ltd founded in 1981. The firm is headquartered in West Conshohocken, Pennsylvania. | Finance |
Desitin Arzneimittel GmbH
Desitin Arzneimittel GmbH Pharmaceuticals: MajorHealth Technology Desitin Arzneimittel GmbH manufactures pharmaceutical products for neurological and psychiatric illnesses. Its products are geared towards the treatment of epilepsy, migraine and Parkinson's disease. The company was founded in 1919 and is headquartered in Hamburg, Germany. | Health Technology |
